Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Giuseppe Remuzzi

Showing results (581-590 of 895) with videos related to

Pageof 90
Sort By:
Iscience|September 27, 2023
Thyroid hormone treatment counteracts cellular phenotypical remodeling in diabetic organsAngelo M Lavecchia, Polyxeni Mantzouratou, Domenico Cerullo, et al.
Lancet (London, England)|November 9, 2010
Selective vitamin D receptor activation with paricalcitol for reduction of albuminuria in patients with type 2 diabetes (VITAL study): a randomised controlled trialDick de Zeeuw, Rajiv Agarwal, Michael Amdahl, et al.
Journal of the American Society of Nephrology : JASN|May 28, 2009
ABCB1 genotypes predict cyclosporine-related adverse events and kidney allograft outcomeDario Cattaneo, Piero Ruggenenti, Sara Baldelli, et al.
The American Journal of Pathology|May 28, 2013
Angiotensin II contributes to diabetic renal dysfunction in rodents and humans via Notch1/Snail pathwayElena Gagliardini, Norberto Perico, Paola Rizzo, et al.
Diabetologia|April 2, 2017
MicroRNA-184 is a downstream effector of albuminuria driving renal fibrosis in rats with diabetic nephropathyCristina Zanchi, Daniela Macconi, Piera Trionfini, et al.
Journal of the American Society of Nephrology : JASN|February 3, 2023
Intensive BP Control in Patients with CKD and Risk for Adverse OutcomesElaine Ku, Charles E McCulloch, Lesley A Inker, et al.
American Journal of Kidney Diseases : the Official Journal of the National Kidney Foundation|December 27, 2023
Anti-Phospholipase A2 Receptor 1 and Anti-Cysteine Rich Antibodies, Domain Recognition and Rituximab Efficacy in Membranous Nephropathy: A Prospective Cohort StudyPiero Ruggenenti, Linda Reinhard, Barbara Ruggiero, et al.
Journal of the American Society of Nephrology : JASN|March 26, 2015
Anti-Phospholipase A2 Receptor Antibody Titer Predicts Post-Rituximab Outcome of Membranous NephropathyPiero Ruggenenti, Hanna Debiec, Barbara Ruggiero, et al.
Journal of the American Society of Nephrology : JASN|June 24, 2003
Add-on anti-TGF-beta antibody to ACE inhibitor arrests progressive diabetic nephropathy in the ratAriela Benigni, Carla Zoja, Daniela Corna, et al.
Hypertension (Dallas, Tex. : 1979)|January 28, 2004
L-arginine depletion in preeclampsia orients nitric oxide synthase toward oxidant speciesMarina Noris, Marta Todeschini, Paola Cassis, et al.
Pageof 90

Showing results (581-590 of 895) with videos related to

Sort By:
Pageof 90
Iscience|September 27, 2023
Thyroid hormone treatment counteracts cellular phenotypical remodeling in diabetic organsAngelo M Lavecchia, Polyxeni Mantzouratou, Domenico Cerullo, et al.
Lancet (London, England)|November 9, 2010
Selective vitamin D receptor activation with paricalcitol for reduction of albuminuria in patients with type 2 diabetes (VITAL study): a randomised controlled trialDick de Zeeuw, Rajiv Agarwal, Michael Amdahl, et al.
Journal of the American Society of Nephrology : JASN|May 28, 2009
ABCB1 genotypes predict cyclosporine-related adverse events and kidney allograft outcomeDario Cattaneo, Piero Ruggenenti, Sara Baldelli, et al.
The American Journal of Pathology|May 28, 2013
Angiotensin II contributes to diabetic renal dysfunction in rodents and humans via Notch1/Snail pathwayElena Gagliardini, Norberto Perico, Paola Rizzo, et al.
Diabetologia|April 2, 2017
MicroRNA-184 is a downstream effector of albuminuria driving renal fibrosis in rats with diabetic nephropathyCristina Zanchi, Daniela Macconi, Piera Trionfini, et al.
Journal of the American Society of Nephrology : JASN|February 3, 2023
Intensive BP Control in Patients with CKD and Risk for Adverse OutcomesElaine Ku, Charles E McCulloch, Lesley A Inker, et al.
American Journal of Kidney Diseases : the Official Journal of the National Kidney Foundation|December 27, 2023
Anti-Phospholipase A2 Receptor 1 and Anti-Cysteine Rich Antibodies, Domain Recognition and Rituximab Efficacy in Membranous Nephropathy: A Prospective Cohort StudyPiero Ruggenenti, Linda Reinhard, Barbara Ruggiero, et al.
Journal of the American Society of Nephrology : JASN|March 26, 2015
Anti-Phospholipase A2 Receptor Antibody Titer Predicts Post-Rituximab Outcome of Membranous NephropathyPiero Ruggenenti, Hanna Debiec, Barbara Ruggiero, et al.
Journal of the American Society of Nephrology : JASN|June 24, 2003
Add-on anti-TGF-beta antibody to ACE inhibitor arrests progressive diabetic nephropathy in the ratAriela Benigni, Carla Zoja, Daniela Corna, et al.
Hypertension (Dallas, Tex. : 1979)|January 28, 2004
L-arginine depletion in preeclampsia orients nitric oxide synthase toward oxidant speciesMarina Noris, Marta Todeschini, Paola Cassis, et al.
Pageof 90